Similar articles

• Abstracts of the 2011 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference. December 1-3, 2011. Hollywood, Florida, USA.

  [No authors listed] [No authors listed] Inflamm Bowel Dis. 2011 Dec;17 Suppl 2:S1-99. doi: 10.1002/ibd.21939. Inflamm Bowel Dis. 2011. PMID: 22072394 No abstract available.
• Abstracts of the 2009 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's National Clinical & Research Conference. December 3-6, 2009. Hollywood, Florida, USA.

  [No authors listed] [No authors listed] Inflamm Bowel Dis. 2009 Dec;15 Suppl 2:S1-65. doi: 10.1002/ibd.21172. Inflamm Bowel Dis. 2009. PMID: 21157881 No abstract available.
• Abstracts of the 2010 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference. December 9-12, 2010. Hollywood, Florida, USA.

  [No authors listed] [No authors listed] Inflamm Bowel Dis. 2011 Jan;17 Suppl 1:S1-75. doi: 10.1002/ibd.21581. Inflamm Bowel Dis. 2011. PMID: 21136586 No abstract available.
• CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.

  van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW. van der Linde K, et al. Eur J Gastroenterol Hepatol. 2007 Jun;19(6):449-59. doi: 10.1097/01.meg.0000236887.44214.6a. Eur J Gastroenterol Hepatol. 2007. PMID: 17489054 Review.
• Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

  Magro F, Portela F. Magro F, et al. BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.